Estrella Immunopharma Inc
ESLA
Get informed when a big investor buys or sells
+ FollowMarket Cap$42.85M
Close$
$0.04
96.2% downside
Current Fair Value
96.2% downsideOvervalued by 96.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $42.85 Million |
|---|---|
| Enterprise Value | $42.70 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.35 |
| Beta | 0.93 |
| Outstanding Shares | 42,997,733 |
Return
| Return on Equity | 134.74% |
|---|---|
| Return on Assets | -548.74% |
| Return on Invested Capital | 130.29% |
Valuation & Multiples
| P/E Ratio | -4 |
|---|---|
| PEG | 6.85 |
| Price to Sales | - |
| Price to Book Ratio | -0.99 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -4.41 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
$-0.09
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 11.15%▼ 1.15% |
|---|---|
| Total Invested | $4.99M▼ 9.17% |
| Investors Holding | 15▼ 1.00% |
ESG Score
No data